Actively Recruiting
Bergamo Lymphoid Cancer Registry
Led by A.O. Ospedale Papa Giovanni XXIII · Updated on 2024-03-06
6000
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Lymphoid cancer, including Hodgkin disease, non-Hodgkin lymphomas, and myeloma, is the most common blood cancer. Researchers are working to better understand the clinical and biological features of patients with these cancers and how they respond to treatments in real-world settings. This observational study collects detailed information to address challenges like treatment resistance, disease recurrence, and outcomes with new drugs. Patients' clinical data and biological samples are gathered through a registry managed by the Hematology and Bone Marrow Transplant Unit at Ospedale Papa Giovanni XIII in Bergamo. Standard procedures are followed for collecting treatments and clinical information. The study collects data over a long period to analyze treatment patterns and support research that may impact clinical care. Participants provide informed consent and their medical information is recorded in validated electronic charts along with biological specimens stored via a regulated biobank. The study tracks overall survival, disease-free survival, progression-free survival, and biological studies over 20 years. This long-term follow-up helps researchers learn more about lymphoid cancer outcomes and biology to improve future patient care.
CONDITIONS
Brief Title
Bergamo Lymphoid Cancer Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female patients 18 years or older
- Written informed consent
- Confirmed diagnosis of Hodgkin disease, non-Hodgkin lymphomas or myeloma
You will not qualify if you...
- Unconfirmed diagnosis of Hodgkin disease, non-Hodgkin lymphomas or myeloma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 20 years
Participants who undergo routine care are observed to collect clinical and biological information related to lymphoid cancer.
Regular visits according to standard clinical practice
Trial Site Locations
Total: 1 location
1
Hematology and Bone Marrow Transplant Unit, A.O. Ospedale Papa Giovanni XXIII
Bergamo, Italy, 24127
Actively Recruiting
Research Team
A
Alessandro Rambaldi, MD
G
Giuseppe Gritti, MD, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here